Clinical trial
Phase I Study of ZD6474 and Temozolomide in Patients With Advanced Cancer
NCT00601614 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I Study of ZD6474 and Temozolomide in Patients With Advanced Cancer
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- January 31, 2008
- Completion date
- Not reported
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
unspecified adult solid tumor, protocol specific